Form 4: Revvity SVP Vohra Reports Equity Transactions

Revvity's Senior Vice President of Global Operations, Tajinder S. Vohra, reported the vesting of restricted stock units, associated tax withholdings, and the grant of new equity awards.

Summary

• Tajinder S. Vohra, Senior Vice President, Global Operations at Revvity, Inc., reported equity transactions on February 4, 2026.
• 359 shares of common stock were disposed of at $101.13 per share to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) originally granted on February 4, 2025.
• 4,448 shares of common stock were acquired as time-based restricted stock units, which are scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date.
• 12,722 non-qualified stock options were acquired with an exercise price of $103.395 per share, also scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date.
• Following these transactions, Vohra beneficially owns 14,531 shares of common stock and 12,722 non-qualified stock options.
• An administrative error in the vesting schedule for a previous RSU grant (reported in a Form 4 filed on February 6, 2025) was noted, clarifying that it vests in three equal annual installments from the grant date.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting ongoing executive compensation and retention efforts through new equity grants, which aligns management interests with long-term shareholder value. The tax-related share disposal is a routine event.

Positives

• Acquisition of 4,448 shares of common stock through restricted stock units, increasing direct beneficial ownership.
• Grant of 12,722 non-qualified stock options, providing future equity upside potential.
• The vesting schedules for new grants are structured over three years, aligning executive incentives with long-term company performance.

Negatives

• Disposal of 359 shares of common stock at $101.13 to cover tax withholding obligations, reducing direct share count.

Future Outlook

The filing details future vesting schedules for newly granted restricted stock units and non-qualified stock options, indicating a multi-year incentive structure for the Senior Vice President of Global Operations.

Management Comments

• The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error.

Industry Context

StockSavvy.ai notes that these equity transactions are standard executive compensation practices within the life sciences and diagnostics industry, aiming to align management incentives with shareholder value creation over the long term. The grants reflect ongoing compensation structures for key executives.

Comparison to Industry Standards

• These equity grants and vesting schedules are consistent with typical executive compensation packages in the biotechnology and life sciences sectors.
• Similar multi-year vesting schedules for RSUs and stock options are common at companies like Thermo Fisher Scientific (TMO) and Danaher Corporation (DHR), which also utilize performance-based and time-based equity awards to retain talent and incentivize growth.
• The tax withholding mechanism is also a standard practice across industries for RSU vesting.

Corporate Governance

Related Party Transactions

• The transactions involve equity compensation granted by Revvity, Inc. to its Senior Vice President, Tajinder S. Vohra, which is a standard related-party transaction in the context of executive compensation.

Stakeholder Impact

• Shareholders: The grant of new equity awards to a key executive aligns management incentives with shareholder interests, potentially fostering long-term value creation. The disposal of shares for tax purposes is a minor, routine event.
• Employees: Reflects the company's ongoing executive compensation strategy, which can influence broader compensation philosophies within the organization.
• Management: Tajinder S. Vohra's equity holdings and future vesting schedules are updated, impacting personal wealth and long-term commitment to the company.

Next Steps

• The newly granted restricted stock units are scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date (February 4, 2026).
• The newly granted non-qualified stock options are scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date (February 4, 2026).

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including RSU vesting, tax withholdings, and new equity grants. While the new grants align executive incentives, these are standard occurrences and do not present new fundamental information that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Revvity, RVTY, Tajinder S. Vohra, Form 4, SEC filing, insider transaction, equity compensation, restricted stock units, stock options, tax withholding, executive compensation